Literature DB >> 33678159

microRNA-125b-5p is a promising novel plasma biomarker for alveolar echinococcosis in patients from the southern province of Qinghai.

Cao Deping1, Jiang Bofan2, Zhang Yaogang3, Pang Mingquan3.   

Abstract

BACKGROUND: Alveolar echinococcosis (AE) is caused by parasitic infection by Echinococcus multilocularis. Its diagnosis is usually based on clinical symptoms, ultrasound, and other imaging methods. MicroRNAs (miRNAs) play important roles in disease processes and can exist in a highly stable cell-free form in body fluids. It is important to identify specific, sensitive diagnostic markers for early diagnosis and evaluation of AE. In this study, we examined hsa-miR-125b-5p as a potential plasma biomarker of E. multilocularis infection.
METHODS: Plasma samples from patients with AE and healthy individuals were screened for the presence of five miRNAs using miRNA chips. We used quantitative polymerase chain reaction to measure miRNA expression levels in plasma and liver tissue samples from patients with AE.
RESULTS: hsa-miR-125b-5p was stably upregulated in the plasma and liver tissue samples from patients with AE.
CONCLUSIONS: The results suggest that hsa-miR-125b-5p may be a promising biomarker for early, non-invasive diagnosis of AE.

Entities:  

Keywords:  Alveolar echinococcosis; Biomarker; Echinococcus multilocularis; Plasma; hsa-miR-125b-5p

Mesh:

Substances:

Year:  2021        PMID: 33678159      PMCID: PMC7938541          DOI: 10.1186/s12879-021-05940-z

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  35 in total

1.  Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation.

Authors:  Yong Sun Lee; Hak Kyun Kim; Sangmi Chung; Kwang-Soo Kim; Anindya Dutta
Journal:  J Biol Chem       Date:  2005-02-18       Impact factor: 5.157

Review 2.  Transmission ecology of Echinococcus multilocularis: what are the ranges of parasite stability among various host communities in China?

Authors:  Patrick Giraudoux; David Pleydell; Francis Raoul; Jean-Pierre Quéré; Qian Wang; Yurong Yang; Dominique A Vuitton; Jiamen Qiu; Wen Yang; Philip S Craig
Journal:  Parasitol Int       Date:  2005-12-19       Impact factor: 2.230

Review 3.  Hepatic echinococcosis: clinical and therapeutic aspects.

Authors:  Giuseppe Nunnari; Marilia R Pinzone; Salvatore Gruttadauria; Benedetto M Celesia; Giordano Madeddu; Giulia Malaguarnera; Piero Pavone; Alessandro Cappellani; Bruno Cacopardo
Journal:  World J Gastroenterol       Date:  2012-04-07       Impact factor: 5.742

4.  Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases.

Authors:  Shashi Bala; Jan Petrasek; Shiv Mundkur; Donna Catalano; Ivan Levin; Jeanine Ward; Hawau Alao; Karen Kodys; Gyongyi Szabo
Journal:  Hepatology       Date:  2012-07-26       Impact factor: 17.425

Review 5.  Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern.

Authors:  Johannes Eckert; Peter Deplazes
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

6.  Serum microRNA-125b correlates with hepatitis B viral replication and liver necroinflammation.

Authors:  F Li; P Zhou; W Deng; J Wang; R Mao; Y Zhang; J Li; J Yu; F Yang; Y Huang; M Lu; J Zhang
Journal:  Clin Microbiol Infect       Date:  2016-01-21       Impact factor: 8.067

7.  miR-182 and miR-10a are key regulators of Treg specialisation and stability during Schistosome and Leishmania-associated inflammation.

Authors:  Samir Kelada; Praveen Sethupathy; Isobel S Okoye; Eleni Kistasis; Stephanie Czieso; Sandra D White; David Chou; Craig Martens; Stacy M Ricklefs; Kimmo Virtaneva; Dan E Sturdevant; Stephen F Porcella; Yasmine Belkaid; Thomas A Wynn; Mark S Wilson
Journal:  PLoS Pathog       Date:  2013-06-27       Impact factor: 6.823

8.  Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection.

Authors:  Peng Qi; Shu-qun Cheng; Hao Wang; Nan Li; Yue-feng Chen; Chun-fang Gao
Journal:  PLoS One       Date:  2011-12-08       Impact factor: 3.240

9.  Parasite-derived circulating microRNAs as biomarkers for the detection of human Schistosoma japonicum infection.

Authors:  Yi Mu; Pengfei Cai; Remigio M Olveda; Allen G Ross; David U Olveda; Donald P McManus
Journal:  Parasitology       Date:  2019-12-16       Impact factor: 3.234

Review 10.  Circulating microRNAs as non-invasive biomarkers for hepatitis B virus liver fibrosis.

Authors:  Diana Gabriela Iacob; Adelina Rosca; Simona Maria Ruta
Journal:  World J Gastroenterol       Date:  2020-03-21       Impact factor: 5.742

View more
  4 in total

1.  Albendazole reduces hepatic inflammation and endoplasmic reticulum-stress in a mouse model of chronic Echinococcus multilocularis infection.

Authors:  Michael Weingartner; Simon Stücheli; Fadi Jebbawi; Bruno Gottstein; Guido Beldi; Britta Lundström-Stadelmann; Junhua Wang; Alex Odermatt
Journal:  PLoS Negl Trop Dis       Date:  2022-01-14

2.  Identification and Expression Profiling of Circulating MicroRNAs in Serum of Cysticercus pisiformis-Infected Rabbits.

Authors:  Guoliang Chen; Liqun Wang; Tingli Liu; Yanping Li; Shaohua Zhang; Hong Li; Xuenong Luo
Journal:  Genes (Basel)       Date:  2021-10-09       Impact factor: 4.096

3.  The Recombinant Eg.P29-Mediated miR-126a-5p Promotes the Differentiation of Mouse Naive CD4+ T Cells via DLK1-Mediated Notch1 Signal Pathway.

Authors:  Xiancai Du; Mingxing Zhu; Tingrui Zhang; Chan Wang; Jia Tao; Songhao Yang; Yazhou Zhu; Wei Zhao
Journal:  Front Immunol       Date:  2022-02-08       Impact factor: 7.561

4.  Micro-RNAs from Plasma-Derived Small Extracellular Vesicles as Potential Biomarkers for Tic Disorders Diagnosis.

Authors:  Yilong Wang; Xuebin Xu; Haihua Chen; Mengying Zhu; Xiaotong Guo; Feng Gao
Journal:  Brain Sci       Date:  2022-06-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.